Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1 1

Status

Completed 3Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 20Genitourinary 10Gastrointestinal 7Lymphoid 5Other hematologic neoplasm 4Other 3Dermatologic 3Thoracic 2Endocrine 2CNS 2Head & Neck 1Gynecologic 1

Conditions

Melanoma, Cutaneous Malignant 1Melanoma 1Keratosis, Actinic 1

Interventions

Ipilimumab 123pembrolizumab 101Nivolumab 100aldesleukin 89Cyclophosphamide 85fludarabine phosphate 64Interleukin-2 58Dacarbazine 573-ingenyl angelate 42Vemurafenib 39Temozolomide 39Imiquimod 39trametinib 37sargramostim 37Peripheral Blood Stem Cell Transplantation 36incomplete Freund's adjuvant 35dabrafenib 32fludarabine 31Radiotherapy 31Aminolevulinic Acid 30Bevacizumab 29Carboplatin 28Whole-Body Irradiation 25Photochemotherapy 25Paclitaxel 25Filgrastim 25Biopsy 25Interferon-alpha 24Cisplatin 23Sorafenib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Vitamin D × Dermatologic × Clear all
NCT01748448 2025-02-17

ViDMe

Universitaire Ziekenhuizen KU Leuven

Phase 3 Completed
436 enrolled 16 charts
Dermatologic

Melanoma, Cutaneous Malignant

NCT01477463 2016-12-23

Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers

Stanford University

Phase NA Completed
24 enrolled 7 charts
Dermatologic

Melanoma

NCT02976727 2016-11-29

Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic Keratosis

Dong-A University

Phase 1 Completed
48 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡